Technology
Health
Pharmaceutical

Harrow Health

$5.32
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.43 (8.79%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, ETFs, and crypto commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. Read More The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx and Park Compounding businesses. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Employees
134
Headquarters
San Diego, California
Founded
2006
Market Cap
131.43M
Price-Earnings Ratio
5.53
Dividend Yield
0.00
Average Volume
478.32K
High Today
$5.58
Low Today
$4.92
Open Price
$5.10
Volume
489.39K
52 Week High
$8.99
52 Week Low
$2.22

Collections

Technology
Health
Pharmaceutical
Medical
US
North America

HROW Earnings

-$0.16
$0.14
$0.43
$0.73
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.07 per share
Actual
Available Aug 14, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.